Chapter 292: Really Fragrance Warning

Clinical work is monotonous and some are very boring.

However, in addition to clinical work today, Lu Chen also has to help Wang Zihao collect patient data information.

He had promised Wang Zihao before that he would assist him in completing the project preparation.

There are three requirements for professional graduate students to graduate from Jinghua Second Hospital.

First, publish at least one Chinese core paper. Of course, if you want to publish an SCI paper or a Chinese series paper, that would be even better!

Second, complete a research project independently and write a paper. This paper does not need to be published publicly, but it is better to be published.

Third, complete the regular training rotation plan and pass the final graduation exam.

Among them, there is no time limit for the paper to be published.

However, the research project completed independently will be started in the first year of graduate school, concluded before graduation, and the graduation thesis will be submitted.

Therefore, many freshmen in the first year of graduate school will start preparing for the project in the first semester of the first year of graduate school.

…

In the morning.

After Lu Chen finished his work, he began to record some data for Wang Zihao.

Wang Zihao did not need much data, but it still took some effort to find it.

Lu Chen found a quiet corner, turned on the computer, and began to compare the data carefully.

After spending a whole morning, Lu Chen was almost familiar with the entire data collection process.

In the afternoon, there were no new patients admitted to the hospital.

Lu Chen continued to collect data with full concentration.

On the other side, Wang Ruoxi delivered lunch to Wang Zihao at noon, and came to the eighth area of ​​the cardiology department in the afternoon, took the examination form, and went to do the exercise treadmill test.

"The results of the exercise treadmill test are normal."

After Wang Ruoxi finished the examination, Lu Chen quickly got the results.

It showed that everything was normal!

"Well, at your age, with the examination of the treadmill exercise test, coronary heart disease has been basically ruled out." Lu Chen said.

Wang Ruoxi looked at the report in her hand, and her heart was slightly relieved.

"Wait until tomorrow to complete some other examinations, and then see what the situation is."

"Okay."

At present, from the preliminary point of view, Wang Ruoxi's examination reports are all normal.

She is likely to just have benign chest pain or cardiac neurosis.

...

Return to the dormitory at night.

Lu Chen sorted out the data he had collected for Wang Zihao.

"There are about 3/4 of the data left..."

After Lu Chen figured out the trick, he collected data very quickly. It was estimated that in another three or four days, he would be able to help Wang Zihao complete everything.

He thought of what he had promised Ke Yue this morning.

Lu Chen called up his own project from the computer - Dapagliflozin prevents the occurrence of early heart failure in patients with acute myocardial infarction.

That's right, it's the hypoglycemic drug Dapagliflozin!

Lu Chen previously recommended this drug to his cousin Li Huiyan for weight loss.

Dapagliflozin is the world's first sodium-glucose cotransporter 2 (sglt2) inhibitor.

In addition to lowering blood sugar, it has many other functions, including protecting kidney function, reducing urine protein, and even treating heart failure.

In the latest heart failure guidelines, Dapagliflozin has been regarded as a must-have drug for the treatment of heart failure!

This means that regardless of whether you have diabetes or not, you can use Dapagliflozin to treat heart failure!

Lu Chen's project was also inspired by this recent guideline.

Since dapagliflozin can treat heart failure, can it prevent heart failure caused by myocardial infarction in advance?

As the saying goes, prevention is better than cure.

If the disease can be nipped in the bud, it must be the best choice!

Therefore, Lu Chen thought of his own topic - dapagliflozin prevents the occurrence of early heart failure in patients with acute myocardial infarction.

In addition, he also read many domestic and foreign literatures and did not see any similar research.

This fills the research gap at home and abroad!

...

Although Lu Chen trusts Ke Yue more, in order to prevent the content of the topic from being leaked.

Lu Chen sent a small part of his research to Ke Yue.

What Ke Yue needs to do for Lu Chen is very simple, that is, collect patient information and then draw blood!

First, collect which myocardial infarction patients have used dapagliflozin, use this as a baseline for blood collection, and then notify the patients to come to the hospital for reexamination regularly.

By comparing the conditions of patients who use dapagliflozin and those who do not use dapagliflozin, follow up the patients' cardiac function status, and draw the final conclusion.

Jinghua Second Hospital, Regular Training Building.

Ke Yue received an email from Lu Chen.

The content collected is not much, but the whole process is relatively cumbersome.

The most important thing is that the follow-up period of the whole project is very long, at least four to six months.

"Xiaoyue, your classmate asked you to help with a lot of things!"

Ke Yue's roommate Wang Xiaoping is also a graduate student in the Department of Cardiology this year, but he is a student in the second district of Cardiology.

"Your senior sister asked you to help with so many things, but you didn't get anything in the end. Now it's this classmate again, you have to learn from your mistakes!" Wang Xiaoping sat next to Ke Yue and muttered.

Ke Yue paused and said, "Xiaoping, I know you are doing this for my own good, but this time I took the initiative to agree."

"Hey, this is very troublesome, to collect so much data." Wang Xiaoping frowned.

"It's less than what my senior sister asked me to do before." Ke Yue suddenly said, "Do you know who my classmate is?"

"Who?" Wang Xiaoping asked curiously.

"Lu Chen..."

When Ke Yue said this name, Wang Xiaoping was stunned.

"Ah? It's Lu Chen!"

A hint of surprise flashed in her eyes.

It's the famous figure of Jinghua Cardiology Department!

Not only did he represent Jinghua Medical University to win the championship of the National Medical Skills Competition, but he also entered the national finals of the electrocardiogram!

Although Wang Xiaoping has never met Lu Chen, he has long been tired of hearing his name.

"This Lu Chen's project?" Wang Xiaoping asked again.

Ke Yue nodded: "Yes."

"Then... Xiaoyue, why don't you talk to Lu Chen, I can also help collect data together!"

Wang Xiaoping's sudden words made Ke Yue stunned.

Ah? Isn't this a warning?

"Xiaoping, didn't you just say that there is too much data..."

Wang Xiaoping immediately interrupted Ke Yue's words.

"Oh, there is a lot of data, so it would be much more convenient if we collect it together."

Ke Yue smiled, "You just asked me to refuse."

"Well... I know that the fellow student you are talking about is Lu Chen!" Wang Xiaoping shrugged his shoulders, "If I knew it was Lu Chen, I would definitely not say that."

"But Lu Chen has never done any scientific research before. What if our work is in vain..." Ke Yue reminded.

Ke Yue and Wang Xiaoping's roles seemed to have suddenly switched!

Wang Xiaoping put his right hand on Ke Yue's shoulder and smiled, "Don't worry, Lu Chen is such an excellent person, will he let himself do useless work?"

"That makes some sense..." Ke Yue nodded slightly.

...

At this time, Lu Chen, who was in the dormitory, received Ke Yue's reply.

"Hey, Ke Yue wants her roommate to help too?" Lu Chen smiled, "I was worried that there was too much data and I couldn't finish it alone!"

Clinical research is not as precise as basic research, and requires a large amount of samples.

Generally, clinical project groups have large teams.

It would be difficult for Lu Chen to complete this project alone.

He quickly replied to Ke Yue.

"You can ask your roommate to join us, so that we can meet and get to know each other."

However, the more participants, the better. Lu Chen currently controls the number of people in his research group to less than three.